<DOC>
	<DOCNO>NCT01886794</DOCNO>
	<brief_summary>Our primary aim current study determine important tissue difference , include muscle connective tissue change , postmenopausal woman reproductive age woman pelvic floor dysfunction help develop targeted noninvasive treatment .</brief_summary>
	<brief_title>Hormonal Status Blood Flow Tissue Pelvic Organ Prolapse</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<mesh_term>Pelvic Floor Disorders</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>21 70 year age Stage II great pelvic organ prolapse ( POP ) Individuals elect surgery treat POP Willing able comply study procedure Willing able provide write informed consent Contraindication estrogen cream Any medical condition opinion investigator would place subject increase risk participation History connective tissue disease Previous hysterectomy pelvic organ prolapse surgery Known allergic reaction agent require protocol Use hormone therapy postmenopausal woman last 90 day Pregnant lactate female History prior noncompliance presence history psychiatric condition would opinion investigator make difficult subject comply study procedure follow instruction</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>pelvic floor dysfunction</keyword>
	<keyword>pelvic organ prolapse</keyword>
	<keyword>vaginal estrogen effect</keyword>
</DOC>